ELEVAR THERAPEUTICS

Serial Number 98594659
731

Registration Progress

Application Filed
Jun 11, 2024
Under Examination
Nov 12, 2024
Approved for Publication
Sep 17, 2024
Published for Opposition
Sep 17, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: May 12, 2026 138 days

Trademark Image

ELEVAR THERAPEUTICS

Basic Information

Serial Number
98594659
Filing Date
June 11, 2024
Published for Opposition
September 17, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
731
Status Date
Oct 31, 2025
Application
Pending
Classes
005

Rights Holder

Elevar Therapeutics, Inc.

03
Address
1 Bridge Plaza N, Suite 850
Fort Lee, NJ 07024

Ownership History

Elevar Therapeutics, Inc.

Original Applicant
03
Salt Lake City, UT

Elevar Therapeutics, Inc.

Owner at Publication
03
Fort Lee, NJ

Legal Representation

Attorney
Cynthia Johnson Walden

USPTO Deadlines

Next Deadline
138 days remaining
NOA E-Mailed - SOU Required
Due Date
May 12, 2026
Extension Available
Until November 12, 2026

Application History

17 events
Date Code Type Description Documents
Oct 31, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 31, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 31, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 31, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 13, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 13, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 12, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
May 12, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 12, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 17, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 17, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 28, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 14, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 14, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 26, 2024 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jul 26, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 11, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Novel cancer therapies, namely, pharmaceutical preparations and substances for the treatment of cancer

Additional Information

Design Mark
The mark consists of the stylized blue lowercase wording "ELEVAR" above the stylized gray lowercase wording "THERAPEUTICS". Above the letters "A" and "R" in "ELEVAR" is the stylized design of wings in the gradient colors of blue, light blue, and dark blue depicting a bird.
Color Claim
The color(s) blue, light blue, dark blue, and gray is/are claimed as a feature of the mark.
Translation
The English translation of ELEVAR in the mark is to raise.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"